SuRo Capital (NSLR)
A publicly traded fund investing in venture-backed private companies.
Something off on this page? Send us feedback.
SuRo Capital is a Nasdaq-listed business development company that gives public shareholders exposure to venture-backed private companies. It mainly seeks capital gains from equity and equity-linked stakes, using direct deals, secondary purchases, funds, and special-purpose vehicles.
SuRo Capital is a non-diversified closed-end management investment company and business development company focused on late-stage private businesses. Its portfolio work centers on equity and equity-related stakes, including common or preferred stock, warrants, convertible securities, private credit, and positions accessed through direct investments, secondary marketplaces, negotiated purchases, funds, and special-purpose vehicles.
The company’s stated investment themes include artificial intelligence infrastructure and applications, software-as-a-service, financial technology and services, consumer goods and services, education technology, and logistics and supply chain. As a publicly traded vehicle, it gives common shareholders a listed route into an asset class usually reached through venture capital or private equity funds. The structure is shaped by BDC regulation, limited leverage rules, illiquid private-company holdings, and a proposed move to an external adviser that still depends on shareholder approval.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 6, 2026 | Barrington | Target | Target: $18 | Target: $16 |
| May 6, 2026 | Barrington | Target | Target: $15 | Target: $18 |
| Apr 9, 2026 | BTIG | Reiterate | Rating: —Target: $12.50 | Target: $15 |
| Mar 11, 2026 | BTIG | Reiterate | Rating: —Target: $10 | Target: $12.50 |
| Mar 11, 2026 | Barrington | Target | Target: $11 | Target: $15 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $12.94T · Total debt $26.42T · Total assets $420.12T · Shareholders' equity $355.86T
- Revenue
- $299.65B
- Operating income
- $0
- Net income
- $0
HistoryDividendAnnual yield
| Institutions | 20.25% | 5.36M shares | |
|---|---|---|---|
| 75 holders · as of Mar 31, 2026 | |||
| Insiders | 23.60% | 6.25M shares | |
| 10 holders · as of Sep 22, 2026 | |||
| Other | 56.15% | 14.86M shares | |
| remainder | |||
26.47M company shares as of Sep 22, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Robert S. Birch1Insider | 8.28% | 3.12M | filed Apr 13, 2021 |
Division of Investment, Department of Treasury, State of New JerseyInsider | 6.69% | 1.77M | filed Jan 10, 2017 |
Mark D. KleinInsiderdirector, officer: Chairman, CEO and President | 6.66% | 1.76M | filed Sep 22, 2026 |
Gabelli Funds LLCInstitution | 4.93% | 1.30M | as of Mar 31, 2026 |
Gatepass Capital, LLCInstitution | 1.91% | 505,900 | as of Mar 31, 2026 |
- Robert S. Birch's transaction reports restate only vehicles that traded; the 2020 ownership statement (3.12M) less the 932.6K net shares sold since is used instead.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 21, 2026 | Mark D. Klein | director, officer: Chairman, CEO and President | +5,000 | $7.91 |
| Sep 3, 2026 | Ronald M. Lott | director | −5,085 | $9.96 |
| Aug 26, 2026 | Erik A. Falk | director | +50,000 | $10.22 |
| Aug 10, 2026 | Mark D. Klein | director, officer: Chairman, CEO and President | +26,040 | $9.60 |
| Jun 23, 2026 | Ronald M. Lott | director | −500 | $12.35 |
- Destiny Tech100
Closest listed vehicle for private-tech access and secondary sourcing.
- U.S. Global Investors
Listed venture-capital platform for AI, SaaS, and consumer-tech growth.
- Hercules Capital
Largest venture-growth BDC in technology and life sciences.
- Runway Growth Finance
Structured-credit alternative for late-stage venture-backed growth firms.
- Trinity Capital
Growth lender spanning tech, equipment, healthcare, and sponsor finance.
- Horizon Technology Finance
Venture-debt rival for technology and life-sciences growth capital.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| SuRo Capital | $8.30 | +4.01% | $211.3M | 1.7 | — | 0.0 | +79.1% |
| Destiny Tech100 | $30.37 | −2.00% | $944.1M | 3.0 | — | 529.5 | — |
| U.S. Global Investors | $2.99 | −0.66% | $38.0M | 11.5 | — | 4.5 | −123.1% |
| Hercules Capital | $17.32 | −0.32% | $3.25B | 8.7 | 8.9 | 5.6 | +86.7% |
| Runway Growth Finance | $6.75 | +0.90% | $284.1M | 60.8 | 5.1 | 4.5 | +10.1% |
| Trinity Capital | $17.87 | +0.82% | $1.59B | 9.2 | 8.6 | 5.6 | +41.2% |
| Horizon Technology Finance | $4.66 | −0.11% | $233.4M | 13.4 | 6.5 | 2.1 | +2.1% |
| Median | 10.4 | 7.5 | 5.1 | +10.1% |